Acumen Pharmaceuticals, Inc.

Biotechnology company · Newton, Massachusetts, United States · Nasdaq: ABOS

Acumen Pharmaceuticals, Inc. is a biotechnology company headquartered in Newton, Massachusetts, United States. Its shares trade on Nasdaq under the ticker ABOS. It has received 4 US government small-business research awards (SBIR/STTR) from health agencies, $727,861 in total, most recently in 2016. It has reported private securities offerings to the US SEC, most recently $700,000 sold in a notice filed in 2013.

www.acumenpharm.comProfile compiled from public records. Is this your company? Request a correction or update

Acumen Pharmaceuticals at a glance

Typebiotechnology company
HeadquartersNewton, Massachusetts, United States
Stock listingNasdaq: ABOS
SEC industryBiological Products, (No Diagnostic Substances)
Employees (per SBIR records)4
SEC CIK1576885

What does Acumen Pharmaceuticals do?

US government research funding

4 SBIR/STTR small-business research awards from US health agencies, $727,861 in total (2005 to 2016). NIH funding came from the National Institute on Aging.

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $700,000 sold (2013).

Frequently asked questions about Acumen Pharmaceuticals

Where is Acumen Pharmaceuticals headquartered?

Acumen Pharmaceuticals, Inc. is headquartered in Newton, Massachusetts, United States.

What does Acumen Pharmaceuticals do?

Acumen Pharmaceuticals, Inc. is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).

Is Acumen Pharmaceuticals a public company?

Yes. Acumen Pharmaceuticals, Inc. trades on Nasdaq under the ticker ABOS.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Sources

Location data: GeoNames (geonames.org), CC BY 4.0.

Last updated 2026-09-23.

Acumen Pharmaceuticals: Headquarters, Locations & Company Profile (2026) | BioBridgeX